BioSpace News Archive

Resverlogix Corp. held its Annual Meeting of Shareholders in Calgary, Alberta.

Renovia Inc. (Renovia), announced today that a recent peer-reviewed, published study showed that women with stress urinary incontinence (SUI) and mixed urinary incontinence (MUI) consume significantly more medical resources and incur higher costs to payers, compared to women without SUI/MUI.

The latest market analysis report published by Reports and Data, titled ‘Global Autoinjectors Market – Forecast to 2028,’ thoroughly examines the Autoinjectors industry to provide essential data & information for the targeted readers

The latest market analysis report published by Reports and Data, titled ‘Global Immunoprecipitation Market – Forecast to 2028,’ thoroughly examines the Immunoprecipitation industry to provide essential data & information for the targeted readers.

The Japan Patent Office is the first to issue patent on the Company’s biomarker panel for detecting lung cancer, which belongs to a large family of patents that BioMark owns, and complements similar patents currently pending in Canada, China, Europe, and US.

The latest market analysis report published by Reports and Data, titled ‘Global Taxifolin Market – Forecast to 2028,’ thoroughly examines the Taxifolin industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

The latest market analysis report published by Reports and Data, titled ‘Global Urology Instrument Market – Forecast to 2028,’ thoroughly examines the Urology Instrument industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Syphilis Rapid Test Kit Market – Forecast to 2028,’ thoroughly examines the Syphilis Rapid Test Kit industry to provide essential data & information for the targeted readers.

An international collaboration between Bruce Power, Isogen, and ITM Isotope Technologies Munich SE, announced a milestone marking the first instance lutetium-177, a short-lived medical isotope, has been produced in a commercial nuclear power reactor.

Sirnaomics Ltd. (the “Company” or “Sirnaomics”, stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced that the Company’s Chief Technology Officer, Dmitry Samarsky, PhD, will present the latest developments and expanded applications of its Dual-Targeted RNAi therapeutics based on its proprietary GalAhead™ technology and product pipeline, at the 4th Annual RNA Therapeutic: From Concept to Clinic Symposium.